News
The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...
A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...
3d
News-Medical.Net on MSNImmune system selects the best T cells for targeted defenseThe research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...
7d
Clinical Trials Arena on MSNCIRM awards $8m to Tr1X for trial of GvHD prevention drug candidate TRX103The company’s president and head of research and development, Dr Maria Grazia Roncarolo, is leading the trial.
When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...
A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...
The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at Tr1X, with patients enrolling at leading stem cell transplant centers across ...
In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
Why are older people more susceptible to infections than younger people? Why do vaccinations sometimes have less of an effect ...
Three days post viral infection CD8 T cells (red) re-arrest with antigen presenting cells (cyan), where they are supplied with IL-2 by CD4 T cells (yellow), which migrate in a stop and go pattern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results